MarkKupersmithMD

PubMed

• Ophthalmic and Systemic Factors of Acute Nonarteritic Anterior Ischemic Optic Neuropathy in the Quark207 Treatment Trial.
  Mark J Kupersmith, Clare L Fraser, Rachelle Morgenstern, Neil R Miller, Leonard A Levin, Nathalie Jette> ;Ophthalmology. 2024 Jan 10
• Visualization of Optic Nerve Structural Patterns in Papilledema Using Deep Learning Variational Autoencoders.
  Jui-Kai Ray Wang, Edward F Linton, Brett A Johnson, Mark J Kupersmith, Mona K Garvin, Randy H Kardon> ;Translational Vision Science & Technology. 2024 Jan 2
• Reply to Comment on: Race Distribution in Non-Arteritic Anterior Ischemic Optic Neuropathy.
  Ana Banc, Mark Kupersmith, Nancy J Newman, Valérie Biousse> ;American Journal of Ophthalmology. 2023 Aug 1
• 1 citations
  Specific recommendations to improve the design and conduct of clinical trials.
  Mark J Kupersmith, Nathalie Jette> ;Trials. 2023 Apr 10
• 2 citations
  Race Distribution in Nonarteritic Anterior Ischemic Optic Neuropathy.
  Ana Banc, Mark Kupersmith, Nancy J Newman, Valérie Biousse> ;American Journal of Ophthalmology. 2023 Sep 1
• 1 citations
  Archetypal analysis of visual fields in optic neuritis reveals functional biomarkers associated with outcome and treatment response.
  Elena Solli, Hiten Doshi, Tobias Elze, Louis R Pasquale, Joseph Branco, Michael Wall, Mark Kupersmith> ;Multiple Sclerosis and Related Disorders. 2022 Nov 1
• 4 citations
  Unsupervised Machine Learning Shows Change in Visual Field Loss in the Idiopathic Intracranial Hypertension Treatment Trial.
  Hiten Doshi, Elena Solli, Tobias Elze, Louis R Pasquale, Michael Wall, Mark J Kupersmith> ;Ophthalmology. 2022 Aug 1
• 2 citations
  Archetypal Analysis Reveals Quantifiable Patterns of Visual Field Loss in Optic Neuritis.
  Elena Solli, Hiten Doshi, Tobias Elze, Louis Pasquale, Michael Wall, Mark Kupersmith> ;Translational Vision Science & Technology. 2022 Jan 3
• 4 citations
  Report From the National Eye Institute Workshop on Neuro-Ophthalmic Disease Clinical Trial Endpoints: Optic Neuropathies.
  Leonard A. Levin, Mohor Sengupta, Laura J. Balcer, Mark J. Kupersmith, Neil R. Miller> ;Investigative Ophthalmology & Visual Science. 2021 Nov 1
• 6 citations
  Unsupervised Machine Learning Identifies Quantifiable Patterns of Visual Field Loss in Idiopathic Intracranial Hypertension.
  Hiten Doshi, Elena Solli, Tobias Elze, Louis R. Pasquale, Michael A. Wall, Mark J. Kupersmith> ;Translational Vision Science & Technology. 2021 Aug 2
• 18 citations
  Optical Coherence Tomography Neuro-Toolbox for the Diagnosis and Management of Papilledema, Optic Disc Edema, and Pseudopapilledema.
  Patrick A. Sibony, Mark J. Kupersmith, Randy H. Kardon> ;Journal of Neuro-Ophthalmology. 2021 Mar 1
• 9 citations
  Ocular myasthenia gravis – How effective is low dose prednisone long term?
  Rashmi Verma, Gil I. Wolfe, Mark J. Kupersmith> ;Journal of the Neurological Sciences. 2021 Jan 15
• 16 citations
  Assessment of Pediatric Optic Neuritis Visual Acuity Outcomes at 6 Months.
  Stacy L. Pineles, Michael X. Repka, Grant T. Liu, Amy Waldman, Mark Borchert, Sangeeta Khanna, Gena Heidary, Jennifer Graves, Veeral Shah, Mark J. Kupersmith, Raymond ...> ;JAMA Ophthalmology. 2020 Dec 1
• 10 citations
  Long-term efficacy of fractionated conformal radiotherapy for the management of primary optic nerve sheath meningioma.
  Ravi R. Pandit, Liliana Paris, Danielle S Rudich, Robert L. Lesser, Mark J. Kupersmith, Neil R. Miller> ;The British Journal of Ophthalmology. 2019 Oct 1
• 4 citations
  The Effect of Acetazolamide and Weight Loss on Intraocular Pressure in Idiopathic Intracranial Hypertension Patients.
  Rudrani Banik, Mark J. Kupersmith, Jui-Kai Wang, Mona K. Garvin> ;Journal of Glaucoma. 2019 Apr 1
• 11 citations
  Genetic Survey of Adult-Onset Idiopathic Intracranial Hypertension.
  Markus H. Kuehn, Rajashree Mishra, Benjamin Deonovic, Kimberly N Miller, Shana E. McCormack, Grant T. Liu, Mark J. Kupersmith, Michael Wall> ;Journal of Neuro-Ophthalmology. 2019 Mar 1
• 19 citations
  Anti-myelin oligodendrocyte glycoprotein (MOG) antibodies in patients with optic neuritis and seizures.
  Josef Maxwell Gutman, Mark J. Kupersmith, Steven Galetta, Ilya Kister> ;Journal of the Neurological Sciences. 2018 Apr 15
• Corticosteroid Therapy in Nonarteritic Anterior Ischemic Optic Neuropathy: Response.
  Mark J. Kupersmith, Neil R. Miller, Leonard A. Levin> ;Journal of Neuro-Ophthalmology. 2017 Sep 1
• 7 citations
  Nonarteritic Anterior Ischemic Optic Neuropathy Induced Retinal Folds and Deformations.
  Mark J. Kupersmith, Patrick A. Sibony, Sarita Dave> ;Investigative Ophthalmology & Visual Science. 2017 Aug 1
• 11 citations
  Optical Coherence Tomography in Neuroretinitis: Epipapillary Infiltrates and Retinal Folds.
  Luca Zatreanu, Patrick A. Sibony, Mark J. Kupersmith> ;Journal of Neuro-Ophthalmology. 2017 Jun 1
• 27 citations
  Peripapillary Retinal Pigment Epithelium Layer Shape Changes From Acetazolamide Treatment in the Idiopathic Intracranial Hypertension Treatment Trial.
  Jui-Kai Wang, Randy H. Kardon, Johannes Ledolter, Patrick A. Sibony, Mark J. Kupersmith, Mona K. Garvin> ;Investigative Ophthalmology & Visual Science. 2017 May 1
• 19 citations
  The Longitudinal Idiopathic Intracranial Hypertension Trial: Outcomes From Months 6–12
  Michael Wall, Mark J. Kupersmith, Matthew J. Thurtell, Heather E. Moss, Elizabeth Ann Moss, Peggy Auinger> ;American Journal of Ophthalmology. 2017 Apr 1
• 3 citations
  New Treatments in Neuro-Ophthalmology: The Role for Evidence.
  Mark J. Kupersmith, Neil R. Miller, Leonard A. Levin> ;Journal of Neuro-Ophthalmology. 2017 Mar 1
• 19 citations
  Role of vitamin A metabolism in IIH: Results from the idiopathic intracranial hypertension treatment trial.
  Jenny Libien, Mark J. Kupersmith, William S. Blaner, Michael P. McDermott, Shan Gao, Y Liu, James J. Corbett, Michael Wall> ;Journal of the Neurological Sciences. 2017 Jan 15
• 16 citations
  The Effect of Treatment of Idiopathic Intracranial Hypertension on Prevalence of Retinal and Choroidal Folds.
  Mark J Kupersmith, Patrick A. Sibony, Steven E. Feldon, Jui-Kai Wang, Mona K. Garvin, Randy H. Kardon> ;American Journal of Ophthalmology. 2017 Apr 1
• Join now to see all

Journal Articles

• Autoimmune Optic Neuropathy - Evaluation and Treatment.  
  Kupersmith MJ, Burde RM, Warren FA, Klingele TG, Frohman LP, and Mitnick H, J Neurol, Neurosurg, Psychiatr 51:1381-1386
• Evoked Potential Assessment of Cortical Adaptation.  
  Seiple WH, Kupersmith MJ, Nelson JI, Carr RE, Applied Optics 27:1089-1093
• Delayed visual loss in patients with giant cell arteritis.  
  Turbin R, Kupersmith MJ, Invest Ophthalmol Vis Sci 1998;39:S771
• The Optic Neuritis Treatment Trial.  
  Beck RW, Optic Neuritis Study Group, Arch Ophthalmol 106:1051-1053
• Growth Prolactinoma Despite Lowering of Serum Prolactin by Bromocriptine.  
  Kupersmith MJ, Kleinberg D, Warren FA, Budzilovitch G, Cooper P, Neurosurgery 24:417-423
• Neuro-ophthalmological assessment of vision before and after radiation therapy alone for pituitary macroadenomas.  
  Rush SC, Kupersmith MJ, Lerch I, Cooper P, Ransohoff J, and Newall J, J Neurosurg 72:594-599
• Spontaneous Retinal Capillary Reperfusion in a Systemic Illness.  
  Noble K, Kupersmith MJ, Archives of Ophthalmology 109:179180
• Efficacy and Complications of Radiotherapy of Anterior Visual Pathway Tumors.  
  Capo H, Kupersmith MJ, Neurologic Clinics 9:179-203
• VEP Threshold and Suprathreshold Deficits in Amblyopia.  
  Holopigian K, Seiple W, Kupersmith M, Clin Vis Sci 6:109-117
• The Clinical Importance of the Inferolateral Trunk of the Internal Carotid Artery.  
  Capo H, Kupersmith MJ, Berenstein A, Choi IS, Diamond GA, Neurosurgery 28:733-738
• The Clinical Profile of Optic Neuritis. Experience of the Optic Neuritis Treatment Trial.  
  Optic Neuritis Study Group, Arch Ophthalmol 109:1673-1678
• A Randomized, Controlled Trial of Corticosteroids in the Treatment of Acute Optic Neuritis.  
  Beck RW, Cleary PA, Anderson MM, Kupersmith MJ, et al, N Engl J Med 326:581-588
• Evolution of Oculomotor Nerve Palsies.  
  Capo H, Warren F, Kupersmith MJ, J Clin Neuro-Ophthalmol 12:21-25
• A prospective, double-blind, randomized, placebo-controlled trial of methotrexate (combined with corticosteroids) in the treatment of giant cell arteritis (GCA).  
  Speira RF, Mitnick H, Kupersmith MJ, Richmond M, Speira H, Peterson M, Paget SA, Arthritis Rheumatism 1998; 41:9
• Maculopathy Caused by Intra-Arterial Administered Cisplatin and Intravenously Administered Carmustine.  
  Kupersmith MJ, Seiple WH, Holopigian K, Noble K, Hiesiger E, & Warren F, Am J Ophthalmol 113:435-438
• Evaluation of a third cranial nerve palsy: an unresolved issue.  
  Capo H, Warren F, Kupersmith MJ, J Clin Neuro-ophthalmol 12:21-25
• The Benign Course of Cavernous Carotid Aneurysms.  
  Kupersmith MJ, Hurst R, Berenstein A, Choi IS, Jafar J, & Ransohoff J, J Neurosurg 77:690-693
• Optic atrophy fails to alter the flash electroretinogram.  
  Kupersmith MJ, Gupta K, Seiple WH, Holopigian K, Clin Vision Sci 7:247-250
• The Optic Neuritis Treatment. Implications for Clinical Practice.  
  Beck, Optic Neuritis Study Group, Archives of Ophthalmology 110:331-332
• Corticosteroid Treatment of Optic Neuritis. A Need to Change Treatment Practices.  
  Beck RW, Optic Neuritis Study Group, Neurology 42:1133-1135
• Brainstem cavernoma – natural history.  
  Kupersmith MJ, Woo H, NANOS
• Ophthalmoplegia as a Presenting Manifestation of Internal Carotid Artery Dissection.  
  Vargas ME, Desrouleaux JR, Kupersmith MJ, J Clin Neuro-ophthalmol 12:268-271
• Skin Biopsies in the Evaluation of Atypical Optic Neuropathies.  
  Bielory L, Kupersmith M, Warren F, Bystryn J and Frohman L, Ocular Immunol Inflammation 1:231-241
• The Effect of Embolization with N-butyl Cyanoacrylate Prior to Surgical Resection of Cerebral Arteriovenous Malformations.  
  Jafar JJ, Davis AJ, Berenstein A, Choi IS, Kupersmith MJ, J Neurosurg 78:60-69
• Fellow Eye Abnormalities in Acute Unilateral Optic Neuritis: Experience of the Optic Neuritis Treatment Trial.  
  Beck RW, Kupersmith MJ, Cleary PA, Katz BJ, & ONTT Group, Ophthalmology 100:691-698
• Join now to see all

Books/Book Chapters

• Neuro-ophthalmology Enters the Nineties. 
  Chapter: Ocular Myasthenia: Diagnosis and Treatment 
  Page 178 - 182Kupersmith MJ, H, Frohman L, et alEditors: J. Lawton-Smith, R Katz.Dutton Press
• Dopaminergic Ergot Derivatives and Motor Function. 
  Chapter: Modification of the "on-off" Effect with Bromocriptine and Lergotrile 
  Page 285 - 295Lieberman A, Kupersmith M, Gopinathan G, Estey E, and Goldstein MEditors: K. Fuxe, D. Caine.Pergamon Press, Oxford and N.Y
• Catecholamines Basic and Clinical Frontiers. 
  Chapter: Bromocriptine and Lergotrile in Parkinson Disease 
  Page 1584 - 1586Lieberman A, Estey E, Gopinathan G, Kupersmith M, and Goldstein MEditors: E. Usdin, J. Kopin, J Barchas.Pergamon Press, Oxford and N.Y
• Advance in Biochemical Psychopharmacology. 
  Chapter: Bromocriptine in Parkinson's Disease: Report on 106 Patients Treated for Up to 5 Years 
  Page 245 - 253Lieberman A, Kupersmith M, Neophytides A, Gopinathan G, Casson I, Durso R, Foo SH, Khayali M, Tartaro T, and Goldstein MRaven Press, New York
• Parkinson's Disease - Current Progress, Problems and Management. 
  Chapter: The Use of Two New Dopamine Agonists: Pergolide and Lisuride in Parkinson's Disease 
  Page 335 - 356Lieberman A, Neophytides A, Leibowitz M, Kupersmith M, Pact V, Walker R, Zasorin N, Goodgold A, and Goldstein MEditors: U.K. Rinne, M. Klinger, and G. Stamm.Elsevier/North Holland Biomedical Press
• Hospital Medicine. 
  Chapter: Identifying Horner's Syndrome 
  Page 38 - 39Kupersmith M and Ransohoff J
• Current Ocular Therapy. 
  Chapter: Angiomatosis Retinae 
  Kupersmith MJEditors: Fraunfelder, F.T.W.B. Saunders
• Evoked Potentials. 
  Chapter: Electrophysiological Evaluation of Retinal Dysfunction in Ophthalmology 
  Page 333 - 342Kupersmith M and Siegel IEditors: Cracco, R.Q. and Bodis-Wollner, I.Williams and Wilkins
• The Clinical Impact of the Blood Brain Barrier and its Manipulation. 
  Chapter: The Blood Ocular Barriers 
  Kupersmith MJ, Shakib MEditors: Ed Neult.Plenum Medical Book Co
• New Methods of Sensory Visual Testing. 
  Chapter: Contrast Sensitivity Testing 
  Kupersmith MJ, Holopigian K, and Seiple WHEditors: Sadun A and Wall M.
• Biomedical Foundations of Ophthalmology, Vol 2. 
  Chapter: Visual Evoked Potential 
  Kupersmith MJJB Lippincott Co
• The Eye In Systemic Disease. 
  Chapter: Tobacco-Alcohol Amblyopia 
  Page 477 - 479Kupersmith MJEditors: Gold DH, Weingeist TA.
• Duane's Foundations of Clinical Ophthalmology. Volume 2. 
  Chapter: Visual Evoked Potential 
  Kupersmith MJEditors: Tasman W, Jaeger EA.JB Lippincott, Philadelphia
• Ocular Anesthesia. 
  Chapter: Neuro-ophthalmic and Neurological Complications of Ophthalmic Anesthesia 
  Page 151 - 168Kupersmith MJEditors: Greenbaum S.W.B. Saunders
• The Cavernous Sinus: A Comprehensive Text. 
  Chapter: Endovascular techniques in the treatment of cavernous sinus aneurysms 
  Page 155 - 176Niimi Y, Berenstein A, Kupersmith MJEditors: Eisenberg MB, Ossama AM.Lippincott Williams & Wilkins, Philadelphia
• Neurological Therapeutics Principals and Practice. 
  Chapter: Cavernous sinus disorders 
  Kupersmith MJ, Lefton DRMartin Dunitz Publishers, london
• Neurovascular Neuro-ophthalmology. 
  Kupersmith MJSpringer- Verlag, Heidelberg
• The Swept Display Technique: Separation of the X- and Y- Dominated Evoked Potentials. 
  Page 123 - 134Nelson JI, Kupersmith MJ, Seiple WH, Carr REEditors: Nodar, R. and Barber, C.Butterworth Publishers
• Join now to see all

Abstracts/Posters

• Outcome in patients with giant cell arteritis after one year of therapy.
  Kupersmith MJ, Langer R, Paget S, Mitnick H, Speira R, Speira H, AAO, San Francisco
• Homonymous field defect in a HIV negative, at risk individual.
  Warren FA, Vargas ME, Seidman I, & Kupersmith MJ, Frank Walsh Society 24th Annual Meeting, Los Angeles, CA
• Recurrent visual field loss in the Optic Neuritis Treatment Trial.
  Keltner J, Johnson CA, Spurr J, Beck RW, Cleary PA, and the Optic Neuritis Study Group, ARVO Annual Meeting, Sarasota, FL
• VEP amplitude and phase changes following discrete contrast steps.
  Xin D, Kupersmith MJ, Holopigian K, Seiple WH, ARVO Annual Meeting, Sarasota, FL
• Further Studies with Lisuride, a Potent Dopamine and Serotonin Agonist in Patients with Parkinson's Disease Who are No Longer Satisfactorily Responding to Levodopa.
  Lieberman A, Goldstein M, Neophytides A, Leibowitz M, Gopinathan G, Kupersmith MJ, American Society for Clinical Pharmacology and Therapeutics, New Orleans, Louisiana
• Visual deficits in fellow eyes of patients with unilateral optic neuritis: Results of the Optic Neuritis Treatment Trial.
  Kupersmith MJ, Beck RW, Cleary PA, and the Optic Neuritis Study Group, ARVO Annual Meeting, Sarasota, FL
• Neurophysiological Investigation of the 20/20 Eye in Multiple Sclerosis.
  Nelson JI, Kupersmith MJ, Seiple W, Weiss P, Carr R, A.R.V.O
• Normative data for the Pelli-Robson contrast sensitivity chart and for visual acuity in young adults.
  Beck RW, Cleary PA, and the Optic Neuritis Study Group, ARVO Annual Meeting, Sarasota, FL
• Side effects of corticosteroid therapy: Experience of the Optic Neuritis Treatment Trial.
  Chrousous G, Kettah JC, Beck RW, Cleary PA, and the Optic Neuritis Study Group, ARVO Annual Meeting, Sarasota, FL
• Neuro-Ophthalmologic Abnormalities and Percutaneous Transvascular Treatment of Giant Aneurysms of the Cavernous Carotid Artery.
  Kupersmith MJ, Berenstein A, Flamm E, Ransohoff J, 34th Annual Meeting of the American Academy of Neurology, Sheraton Washington Hotel, Washington, D.C
• Intercorrelation of visual function measures in optic neuritis: Experience of the Optic Neuritis Treatment Trial (ONTT).
  Cleary PA, Beck RW, and the Optic Neuritis Study Group, ARVO Annual Meeting, Sarasota, FL
• Exotropia as a sign of myasthenia gravis in dysthyroid ophthalmopathy.
  Warren FA, Vargas EM, and Kupersmith MJ, International Society of Neuro-Ophthalmology, Williamsburgh, Virginia
• Maculopathy caused by intra-arterially administered cisplatin and intravenously administered carmustine.
  Kupersmith MJ, et al, Ophthalmology Digest
• Mechanism for retinal/choroidal visual loss with cavernous sinus arteriovenous shunts.
  Kupersmith MJ, Vargas M, Warren F, Berenstein A, NANOS annual meeting, Big Sky
• The Evaluation of Transvascular Therapy of Intracavernous Carotid Aneurysms and Carotid-Cavernous Sinus Fistulas.
  Kupersmith MJ, Berenstein A, Choi IS, Fourth Meeting of the International Society of Neuro-ophthalmology, Princess Hotel, Bermuda
• Orbital inflammation in giant cell arteritis.
  Kalish H, Kupersmith MJ, Frank Walsh Society, Atlanta
• Cavernous Optic Atrophy with Compressive Lesions of the Anterior Visual Pathway.
  Kupersmith MJ, Krohn D, 107th Annual Meeting of the American Neurological Association, Washington Hilton Hotel, Washington, D.C
• Long term outcome of Terson’s syndrome.
  Kalish H. Kupersmtih MJ, IOVS, ARVO
• The Swept Display Technique: Separation of X- and Y- Dominated Evoked Potentials.
  Nelson JI, Kupersmith MJ, Seiple WH, Carr RE, 2nd International Evoked Potentials Symposium, Stouffer's Inn on the Square, Cleveland, Ohio
• The use of single-photon emission computed tomography in the evaluation traumatic cortical blindness.
  Evans R, Wang JC, Kalish H, Kupersmith MJ, IOVS, ARVO
• Isolated sixth nerve palsy an uncommon presenting sign of multiple sclerosis: a retrospective study.
  Roth R, Kupersmith MJ, Barr D, Turbin R, Bose S, IOVS, ARVO
• The Pattern Electroretinogram in the Assessment of Optic Nerve Disease.
  Price MJ, Seiple WH, Kupersmith MJ, Siegel IM, Carr RE, American Academy of Ophthalmology
• Outcome brainstem cavernoma.
  Kupersmith MJ, Woo H, European Neuro-ophthalmology Society, Jerusalem
• Cavernous carotid aneurysms - long term natural history.
  Kalish H, Kupersmith MJ, European Neuro-ophthalmology Society, Jerusalem
• Acute and subacute complications of GDC treatment of intracranial aneurysms.
  Kupersmith MJ, Alpert R, Berenstein A, et al, AAN
• Join now to see all

Lectures

• Anatomical and Physiological Basis for Understanding the VEP. 
  The New York Academy of Medicine. White Plains, New York
• Long term experience with cavernous carotid aneurysms. 
  Working Group Interventional Neuroradiology, France
• Cavernous Optic Atrophy with Suprasellar Lesions. 
  The New York Glaucoma Round Table. New York, N.Y
• Visual Evoked Potential in Neuro-Ophthalmological Disorders. 
  The New York Ophthalmology Society. New York, New York
• NANOS visual loss from giant cell arteritis. 
• VEP's in Neuro-Ophthalmology". Presented at Continuing Education Course in Ophthalmic Electrodiagnosis. 
  New England Medical Center, The Parker House, Boston, Massachusetts
• Giant Cell Arteritis 1998. 
  Pennsylvania Ophthalmological Association
• Color doppler assessment of orbital blood flow in giant cell arteritis. 
  2nd International Glaucoma Meeting, Jerusalem
• Visual Evoked Potential. 
  55th Annual New York Eye and Ear Infirmary Clinical Conference, New York City
• Aneurysms of the cavernous carotid artery. 
  Interventional Neuroradiology, Val D’Sere
• Divergence insufficiency. 
  American Academy Ophthalmology. New Orleans
• Diagnosis and management of divergence weakness in adults. 
• Pediatric Neuro-ophthalmology. 
  Mount Sinai Medical Center
• Visual Evoked Potentials in Neurological Diseases. 
  New York University Medical Center
• Bilateral Adie's Pupil. 
  Frank Walsh Society Annual Meeting, New Orleans
• Visual Evoked Potentials: Neuroanatomy, Normative Data, Applications and Shortcomings. 
  Kingsbrook Jewish Medical Center
• Performance and Interpretation of Visual Evoked Potentials. 
  Third Annual Workshop on Evoked Potentials, White Plains, N.Y
• Acute homonymous quadrantanopia and patent foramen ovale. 
  Frank Walsh Ann Arbor
• Contrast Sensitivity Determinations in Ophthalmology. 
  Manhattan Ophthalmology Society
• Does Electrophysiologic Testing Have a Role in the Diagnosis of Optic Neuropathies? 
  American Academy of Ophthalmology, Northeast Regional Update Course, Philadelphia
• Neuro-ophthalmology Symposium. 
  Am Acad Ophthalmol, New Orleans
• Ocular myasthenia gravis: edrophonium testing and effects of prednisone on incidence of generalized disease at two years. 
  Utah
• Case report: see-saw nystagmus as the presenting sign in an adult male with mri confirmed agensesis fo the optic chiasm. 
  ARVO, Ft. Lauderdale, FL
• Magnims clinically isolated syndrome workshope. 
  National Hospital at Queens Square London
• 10 year follow up of ONTT study. 
  NANOS, Orlando
• Join now to see all

Other

• Method and apparatus for visual evoked responses. 
  Jeremiah Nelson and Mark Kupersmith, Patent #4,676,611
• Physiological Interpretation of the VER. 
  Kupersmith MJ, Seiple WH, and Nelson JI, Highlights in Neuro-ophthalmology pp.103-114